| 发明名称 |
GLYCAN-INTERACTING COMPOUNDS |
| 摘要 |
The present invention provides glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives and fragments thereof as well as compositions and kits comprising them. |
| 申请公布号 |
US2014178365(A1) |
申请公布日期 |
2014.06.26 |
| 申请号 |
US201314050773 |
申请日期 |
2013.10.10 |
| 申请人 |
SIALIX, INC. |
发明人 |
Ghaderi Darius;da Silva Ana Paula Galvao;Behrens Jeffrey;Hermann Julie;Hurtado-Ziola Nancy |
| 分类号 |
C07K16/30;G01N33/574 |
主分类号 |
C07K16/30 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An isolated antibody directed toward one or more cancer-related antigens, wherein said one or more cancer-related antigens are selected from the group consisting of mucin-related antigens, blood group Lewis-related antigens, glycosphingolipid-related antigens, ganglioside-related antigens and polysialic acid-related antigens. |
| 地址 |
Newton MA US |
